MK
Malvika Kalra
About Malvika Kalra
Data last updated:
Malvika Kalra was a Director at La Pristine Bioceuticals Private Limited (2015–2023), Director at Curewell Pharmakon Private Limited (1989–2017) and Partner at Dermasastra Llp (from 2020), and held 1 more directorship. The companies operate in Pharma and Trading.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Mar 2015 | 2011 | ₹60.46 Cr (FY 2024) | Active | |
| Director | 31 Mar 1989 | 1989 | ₹2.76 Cr (FY 2025) | Active | |
| Partner | 02 Dec 2020 | 2020 | Strike Off | ||
| Partner | 05 Nov 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Malvika Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Malvika Kalra
Malvika Kalra was first appointed on 31 Mar 1989 as Director at Curewell Pharmakon Private Limited. The most recent appointment on record is 02 Dec 2020 at Dermasastra Llp.
Malvika Kalra held 4 earlier board appointments: La Pristine Bioceuticals Private Limited (Director, 25 Mar 2015 to 01 Jun 2023); Curewell Pharmakon Private Limited (Director, 31 Mar 1989 to 17 Nov 2017); Dermasastra Llp (Partner, from 02 Dec 2020); Sanavero Pharmaceutics Llp (Partner, from 05 Nov 2020).